Table 1.

characteristics of the patients (N = 357)

Age (mean years, SD)	75.7 (10.2)
Sex (% male)	52.9
NYHA class (% I & II)	73.1
Optimal pharmacological treatment (% yes)	33.1
ACE/ARB (%)	58.3
β-blockers	46.9
Spironolactone	31.0
Lifestyle advice (0 – 8) (mean, SD)	4.4 (2.7)
Heart signs and symptoms (% yes)	58.3
Type of heart disorder	52.8
Medication intake	54.2
Reduced salt and limited fluid intake	37.5
Physical activity	41.6
Flu prevention	91.1
Weighing regularly	54.7
Coping behaviour	42.8
Quality of Life (0 – 105, less is better) (mean, SD)	30.5 (24.8)
Men	26.3 (1.9)
Women	35.5 (2.4)
NYHA class I	15.5 (1.5)
NYHA class II	36.6 (2.4)
NYHA class III	51.5 (2.7)
NYHA class IV	57.4 (11.3)
≤ 75	27.0 (2.3)
> 75	33.5 (2.0)